NASDAQ:ONCS - OncoSec Medical Incorporated
$2.23
 $0.03
+1.36%
4:00PM EDT
2019-07-15
OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. As of July 31, 2016, the Company was pursuing two Phase II trials: ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma and ImmunoPulse IL-12 plus pembrolizumab in patients with advanced, metastatic melanoma. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple negative breast cancer. Its ImmunoPulse product candidates are based on its deoxyribonucleic acid (DNA)-based immunotherapy technology, which is designed to stimulate the human immune system, resulting in systemic anti-tumor immune responses. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ONCS     avg for
industry  
  avg for
sector  
42 stocks weight:  12. 31   114. 77   204. 78  
42 stocks rank:  3. 61 K 1. 44 K 810. 33  
# analyst opinions:  2. 00   13. 59   13. 86  
mean recommendation:  2. 00   2. 12   2. 04  

quick ratio:  4. 59   5. 48   1. 89  
current ratio:  5. 04   5. 85   2. 40  

target price low:  2. 55   82. 72   115. 11  
target price avg:  2. 86   104. 42   138. 02  
target price high:  3. 18   130. 64   159. 47  
1-yr high:  19. 10   110. 27   142. 72  
last close:  2. 20   85. 12   126. 54  
50-day avg:  3. 25   86. 06   122. 35  
200-day avg:  7. 27   88. 76   121. 75  
1-yr low:  2. 11   69. 26   100. 63  
volume:  408. 23 K 3. 51 M 5. 53 M
50-day avg volume:  227. 17 K 3. 21 M 4. 22 M
200-day avg volume:  155. 33 K 3. 04 M 4. 75 M

1-day return:  -1. 79 % -0. 30 % -1. 01 %
this week return:  -11. 29 % -2. 16 % -1. 35 %
12-wk return:  -61. 40 % 3. 34 % 8. 69 %
52-wk return:  -82. 77 % -1. 76 % 12. 22 %

enterprise value (EV):  3. 45 M 46. 50 B 123. 99 B
market cap:  23. 36 M 40. 77 B 109. 11 B
EBITDA:  -34. 85 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 10   5. 45   12. 05  
total debt:  165. 77 K 11. 27 B 17. 58 B
debt/equity:  0. 78   57. 36   120. 25  
net income (common):  -35. 21 M 2. 13 B 4. 27 B

shares outstanding:  342. 40 K 551. 08 M 1. 24 B
shares:  7. 41 M 559. 41 M 1. 22 B
shares short:  121. 53 K 11. 15 M 11. 94 M
shares short prior month:  303. 24 K 9. 31 M 11. 96 M
short ratio:  0. 34   5. 72   3. 43  
short % of float:  2. 07 % 6. 40 % 2. 65 %
total cash/share:  2. 19   11. 00   9. 23  
total cash:  23. 26 M 6. 03 B 6. 01 B
free cash flow:  -13. 14 M 3. 02 B 4. 96 B
operating cash flow:  -27. 13 M 3. 92 B 5. 99 B

book value:  2. 98   13. 02   27. 49  
price/book:  0. 74   4. 21   8. 80  
operating margins:  0. 00 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  49. 67 % --- ---
1-yr mean volatility:  3. 89 % 1. 50 % 1. 08 %

1-yr EPS:  -5. 93   2. 12   4. 26  
forward EPS:  -3. 37   3. 47   7. 14  
P/E:  -0. 37   2. 15   33. 17  
forward P/E:  -0. 66   -4. 03   17. 60  
PE/G:  0. 01   0. 54   0. 34  
growth:  -65. 31 % 263. 03 % 78. 34 %
earnings high:  -1. 06   0. 91   1. 70  
earnings avg:  -1. 13   0. 71   1. 58  
earnings low:  -1. 20   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -68. 50 % -2. 31 % 5. 31 %
return on equity:  -130. 71 % -82. 48 % 135. 30 %

beta (1yr vs S&P500):  0. 91   1. 26   0. 91  
sharpe (1yr):  -1. 23   0. 07   0. 77  

held % insiders:  18. 21 % 6. 08 % 3. 31 %
held % institutions:  6. 40 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : ONCS
.    101.285 =       101.285 :: --> INITIAL WEIGHT <--
.    - 5.931 =        95.354 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.947 =        185.62 :: P/E factor
.    x 2.209 =       410.026 :: PE/G factor
.    x 1.497 =       613.833 :: beta factor
.    x 0.876 =       537.845 :: sharpe factor
.    x 2.862 =      1539.224 :: current ratio factor
.    x 1.131 =      1740.289 :: quick ratio factor
.    x 1.895 =      3298.572 :: short ratio factor
.    x 1.004 =      3310.734 :: price-to-book factor
.    x 1.007 =      3333.255 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =      7046.449 :: sector+industry 1-year gains factor
.    x 1.033 =      7281.787 :: industry 12-weeks return factor
.    x 1.305 =      9504.725 :: industry 2-weeks return factor
.    x 0.938 =      8920.095 :: "drift" penalty 2 days ago
.     x 0.99 =      8830.674 :: "drift" penalty 3 days ago
.    / 2.155 =       4097.52 :: overall "drift" factor
.    x 0.611 =      2502.247 :: largest single-day jump factor
.    x 0.067 =       167.039 :: low price factor
.    x 1.115 =       186.192 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.679 =       126.477 :: forward EPS factor
.    x 0.883 =       111.737 :: forward P/E factor
.    x 1.182 =       132.123 :: industry recommendation factor
.    x 2.098 =       277.216 :: company recommendation factor
.    x 1.008 =       279.337 :: factor historical industry gain for week 28
.    x 1.492 =       416.876 :: target low factor
.    x 1.183 =       493.263 :: target mean factor
.    x 1.028 =       507.112 :: target high factor
.   x 10.354 =      5250.423 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         8.512 :: reduced for readability
.    + 3.803 =        12.315 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     12.315 :: FINAL WEIGHT for NASDAQ:ONCS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org